This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_SALIVARYNAS_EXALLC for full statistics.
Malignant neoplasm of other and unspecified major salivary glands
C3_SALIVARYNAS
No definition available.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
Cause of death: ICD-10
C08
Cause of death: ICD-9
142
Cause of death: ICD-8
142
Cause of death: excluded ICD-9
1420
Cancer registry: Topography ICD-O-3
C08
Cancer registry: Morphology ICD-O-3
ANY
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
70
Check minimum number of events None
70
Include endpoints None
70
Remove individuals based on genotype QC
70
C3_SALIVARYNAS
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF9
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and unspecified major salivary glands
based on the number of shared cases.
Broader endpoints:
- Malignant neoplasm of other and unspecified major salivary glands (controls excluding all cancers)
- Malignant neoplasm of head and neck (controls excluding all cancers)
- Malignant neoplasm of head and neck
- Malignant neoplasm
- Malignant neoplasm (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 70 | 35 | 35 |
| Unadjusted prevalence (%) | 0.02 | 0.02 | 0.02 |
| Mean age at first event (years) | 63.55 | 62.85 | 64.25 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_SALIVARYNAS – Malignant neoplasm of other and unspecified major salivary glands
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Malignant neoplasm of other and unspecified major salivary glands
↥Endpoint not on priority list, no data to show.